Skip to content
Breaking News Desk Editorial

China’s Anti-Aging Drug PCC1: Can Humans Really Live 150 Years?

China’s Anti-Aging Drug PCC1: Can Humans Really Live 150 Years?
Kanika Sharma
Geopolitical Analyst & Editor
Published: Updated: 2 min read

Chinese scientists are developing a new anti-aging drug called PCC1 (Procyanidin C1) that could reportedly help humans live up to 150 years. The compound, extracted from grape seeds, is being tested by Lonvi Biosciences in Shenzhen.

What is PCC1?

PCC1 or Procyanidin C1 is a natural polyphenol compound found in grape seeds. It works as a senolytic compound, meaning it helps remove old and damaged cells from the body. These so-called “junk cells” cause aging, weakness, inflammation, and age-related diseases. By clearing them, PCC1 allows healthy cells to function better and may slow down the aging process.

What Does the Research Say?

So far, PCC1 has only been tested on mice and tissue models. Results showed positive signs of reduced aging in animals. However, there is no evidence yet that it works the same way in humans. The idea that humans could live up to 150 years remains experimental and unproven.

Expert Opinion

Scientists say it’s too early to claim that PCC1 can extend human life so dramatically. The drug must go through long-term clinical trials, safety tests, and regulatory approvals from agencies like the FDA and WHO. Aging is a complex biological process influenced by thousands of factors, not just cell removal.

Challenges Ahead

  • Human trials are time-consuming and expensive.
  • Multiple regulatory approvals are required.
  • Aging involves genetics, lifestyle, and environment – not just senescent cells.

China’s Larger Plan

China is heavily investing in anti-aging and longevity research. Reports suggest projects like “Immortality Islands” are being developed, where biotechnology and advanced medical research work together to explore life-extension possibilities.

Bottom Line

PCC1 offers an exciting glimpse into the future of anti-aging science. But for now, living to 150 years remains a dream rather than a reality. The journey from lab tests to a safe, effective human drug will take years of careful research and global validation.

⚡ Prime Member Exclusive
Ad-Free News + 100+ Market Tools
No ads. Screener, FII/DII, SLBM, MTF — all in one dashboard.
Join Prime →
Kanika Sharma
Geopolitical Analyst & Editor

Kanika Sharma

Kanika Sharma is a Geopolitical Analyst and Editor at BigBreakingWire. She holds a Master's degree in History from the Central University of Punjab, with an academic background in qualitative research, text analysis, and historical frameworks. At BigBreakingWire, she analyzes global trade shifts, international policies, geopolitical developments, semiconductor supply chains, manufacturing policies, and sovereign industrial initiatives. Her work combines historical context with contemporary policy and macroeconomic analysis to explain complex global developments clearly and accurately.

Last reviewed by Kanika Sharma on February 7, 2026

Disclaimer: BigBreakingWire provides news and informational content for general educational purposes only. The information presented on this website does not constitute financial, investment, tax, or legal advice. Readers should consult qualified professionals before making any financial decisions. BigBreakingWire, its authors, and editors are not responsible for any financial losses or damages arising from the use of information on this site.

⚡ Prime Member Exclusive
Ad-Free News + 100+ Market Tools
No ads. Screener, FII/DII, SLBM, MTF — all in one dashboard.
Join Prime →